call us
Download free PDF

Photon-Counting CT Market Size & Share 2026-2035

Report ID: GMI16260
   |
Published Date: July 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform

Download Free PDF

Explore Our Licensing Options:

Photon-Counting CT Market Size

The global photon-counting CT market was estimated at USD 322.7 million in 2025. The market is expected to grow from USD 395.1 million in 2026 to USD 2.9 billion in 2035, at a CAGR of 24.7% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by numerous factors, such as growing demand for high-resolution diagnostic imaging, and increasing prevalence of chronic diseases and cancer, among other factors.

Photon-Counting CT Market Key Takeaways

2025 Market Size
$ 322.7 Million
2026 Market Size
$ 395.1 Million
2035 Forecast Market Size
$ 2.9 Billion
CAGR (2026–2035)
24.7%
Regional Dominance
Largest Market
North America
Fastest Growing Region
Asia Pacific
Key Players

  • Market Leader: Siemens Healthineers led with over 57% market share in 2025.

  • Leading Players: Top 5 players in this market include Siemens Healthineers, GE HealthCare, PHILIPS, Canon, United Imaging Healthcare, which collectively held a market share of 90% in 2025.

Key Market Drivers
  • Growing demand for high-resolution diagnostic imaging
  • Increasing prevalence of chronic diseases and cancer
  • Rising adoption of advanced CT technologies in healthcare facilities
Opportunity
  • Expansion in emerging healthcare markets
  • Increasing research and development investments
  • Growing adoption in precision medicine and personalized healthcare
Challenges
  • High installation and equipment costs
  • Shortage of trained professionals for operation and interpretation
  • Limited availability of photon-counting CT systems
Get Market Insights & Growth Opportunities

The photon-counting CT market comprises advanced computed tomography imaging systems that use photon-counting detector technology to directly convert individual X-ray photons into electrical signals while measuring their energy levels. These systems are typically equipped with semiconductor-based detectors, high-speed data processing units, and advanced image reconstruction software, enabling superior spatial resolution, enhanced tissue characterization, reduced image noise, and lower radiation exposure compared to conventional CT scanners. Photon-counting CT systems support improved diagnosis across applications such as oncology, cardiovascular diseases, neurology, musculoskeletal disorders, and pulmonary imaging, thereby enhancing diagnostic accuracy, clinical decision-making, and overall patient outcomes.

Rising adoption of advanced CT technologies in healthcare facilities is expected to support the growth of the photon-counting CT market. Siemens Healthineers, GE HealthCare, PHILIPS, Canon, and United Imaging Healthcare are among the leading players operating in the market. These companies primarily focus on technological innovation, product development, strategic collaborations, research and development, and geographic expansion to strengthen their advanced imaging portfolios and enhance their market presence.

The market has increased from USD 160.5 million in 2022 and reached USD 253.9 million in 2024, with a historic growth rate of 25.8%. The increasing prevalence of chronic diseases are key factors driving the growth of the photon-counting CT market, as they accelerate the adoption of next-generation computed tomography technologies. The rising global burden of cardiovascular diseases, cancer, and neurological disorders has significantly increased the need for high-resolution imaging solutions that enable earlier and more accurate diagnosis. According to the World Health Organization (WHO), noncommunicable diseases account for approximately 43 million deaths annually, representing nearly 75% of all global deaths, highlighting the growing need for advanced diagnostic technologies. In addition, the International Agency for Research on Cancer (IARC) estimated that global cancer cases are expected to exceed 35 million by 2050, an increase of approximately 77% compared with 2022 levels. This increasing disease burden is driving demand for photon-counting CT systems, which offer superior spatial resolution, enhanced tissue characterization, reduced radiation dose, and improved diagnostic accuracy, thereby supporting market expansion.

Additionally, the growing demand for high-resolution diagnostic imaging is a key driver in the photon counting CT market, as healthcare providers increasingly prioritize precise visualization for early and accurate disease detection. Photon counting CT technology offers superior spatial resolution, enhanced contrast differentiation, and improved signal-to-noise ratio compared to conventional CT systems, enabling better identification of small lesions and complex anatomical structures. This is particularly critical in applications such as oncology, cardiovascular imaging, and pulmonary diagnostics, where early detection directly impacts treatment outcomes. As clinicians seek more detailed and reliable imaging for improved diagnostic confidence, the demand for high-resolution imaging solutions is accelerating the adoption of photon counting CT systems globally.

Photon-Counting CT Market Research Report
To get key market trends

Photon-Counting CT Market Trends

The advancements in photon-counting detector technology and system architecture play a critical role in driving market growth by enabling superior image quality, reducing radiation exposure, and expanding clinical applications across diagnostic imaging.

  • Technological advancements in detector materials and system design photon-counting CT systems are increasingly being developed using advanced semiconductor detector materials such as cadmium telluride (CdTe), cadmium zinc telluride (CZT), and emerging deep silicon configurations, which provide enhanced photon detection efficiency, improved energy resolution, and greater signal accuracy. These developments support effective spectral imaging and minimize electronic noise, thereby improving diagnostic precision and overall system performance.
  • The integration of advanced image reconstruction algorithms, AI-powered noise reduction, and optimized detector geometries helps maximize image clarity while managing radiation dose, which is critical for pediatric and repeated imaging scenarios. Enhanced system designs also accommodate higher photon flux rates and faster acquisition speeds, while improving workflow integration, thereby supporting better clinical outcomes and broader adoption.
  • For instance, Siemens Healthineers' NAEOTOM Alpha, the first FDA-approved photon-counting CT system in 2021, utilizes CdTe detector technology with ultra-high resolution imaging modes, enabling precise visualization of coronary stents, small pulmonary nodules, and subtle tissue changes for improved diagnostic confidence.
  • Similarly, GE HealthCare's Deep Silicon approach positions silicon sensors edge-on, providing sufficient absorption depth for high-energy photons while maintaining the speed required to count hundreds of millions of photons per second—addressing historical limitations of silicon-based detectors.
  • Collectively, these material and design innovations highlight a strong industry focus on precision-driven, dose-optimized diagnostic solutions, thereby reinforcing advancements in photon-counting CT technologies as a key factor supporting market expansion.

Photon-Counting CT Market Analysis

Photon-Counting CT Market, By Product Type, 2022-2035 (USD Million)

Based on product type, the photon-counting CT market is segmented into standalone photon-counting CT systems and retrofit photon-counting CT solutions. The standalone photon-counting CT systems segment accounted for the dominant market share of 87.9% in 2025, driven by increasing adoption of purpose-built photon-counting CT scanners that deliver superior image quality, enhanced spectral imaging capabilities, and lower radiation doses. The segment is projected to reach USD 2.2 billion by 2035, growing at a CAGR of 23% during the forecast period.

  • The standalone photon-counting CT systems segment represented the dominant product category in the photon-counting CT market, owing to its fully integrated detector architecture, optimized system performance, and superior clinical capabilities compared with conventional CT systems. These systems are specifically designed around photon-counting detector technology, enabling higher spatial resolution, improved contrast-to-noise ratio, enhanced material decomposition, and quantitative spectral imaging. Their ability to provide more accurate diagnosis while reducing radiation exposure has accelerated adoption across tertiary hospitals, academic medical centers, and advanced diagnostic imaging facilities.
  • Furthermore, continuous technological advancements in detector materials, AI-powered image reconstruction, and high-speed data processing are strengthening the value proposition of standalone photon-counting CT systems. The expansion of clinical applications in cardiology, oncology, neurology, vascular imaging, and musculoskeletal imaging, combined with increasing regulatory approvals and growing clinical evidence, continues to reinforce the segment's leadership in the photon-counting CT market.
  • The retrofit photon-counting CT solutions segment is projected to expand at a CAGR of 32.7% to reach USD 663.6 million by 2035. This segment includes photon-counting detector upgrades and retrofit solutions that enable existing CT platforms to incorporate selected photon-counting capabilities without complete system replacement.
  • These solutions offer a comparatively cost-effective pathway for healthcare providers to access advanced imaging technology while extending the operational life of installed CT equipment. Growing demand for budget-friendly modernization, particularly in cost-sensitive and emerging healthcare markets, is expected to support the rapid growth of this segment throughout the forecast period.

Based on detector type, the photon-counting CT market is segmented into silicon detectors, cadmium telluride (CdTe) detectors, cadmium zinc telluride (CZT) detectors, and other detector types. The cadmium telluride (CdTe) detectors segment accounted for the dominant market share of 85.1% in 2025, driven by its widespread adoption in commercial photon-counting CT systems. The segment is projected to reach USD 2.4 billion by 2035, growing at a CAGR of 24.4% during the forecast period.

  • The cadmium telluride (CdTe) detectors segment represented the dominant detector category in the photon-counting CT market. CdTe detectors enable direct conversion of X-ray photons into electrical signals, resulting in improved spatial resolution, enhanced spectral imaging, reduced electronic noise, and lower radiation dose compared with conventional detector technologies. Their proven clinical performance and integration into commercially available photon-counting CT systems continue to drive widespread adoption across leading healthcare institutions.
  • Continuous improvements in count-rate capability, image reconstruction, and detector stability support broader clinical applications in cardiology, oncology, neurology, vascular imaging, and precision diagnostics. These technological developments, combined with increasing investments from major CT manufacturers, continue to reinforce the dominance of CdTe detectors in the global market.
  • The silicon detectors segment is projected to expand at a CAGR of 35.6% to reach USD 317.4 million by 2035. Silicon detectors are gaining attention due to their excellent spatial resolution, fast signal response, and compatibility with advanced semiconductor manufacturing processes. Although their lower X-ray absorption efficiency limits their use in whole-body CT imaging, ongoing research into stacked detector architectures and hybrid detector technologies is expected to expand their adoption in specialized and next-generation photon-counting CT applications.
  • The cadmium zinc telluride (CZT) detectors segment is projected to expand at a CAGR of 13.2% to reach USD 82.7 million by 2035. CZT detectors offer high energy resolution and direct photon conversion capabilities similar to CdTe while providing excellent material discrimination for spectral imaging. They are increasingly utilized in research applications and specialized medical imaging systems, with continued advancements in crystal quality and manufacturing expected to support future commercialization in photon-counting CT platforms.
  • The other detector types segment is projected to expand at a CAGR of 22% to reach USD 72.4 million by 2035. This category includes emerging semiconductor materials and novel detector technologies currently under research and early-stage development. Increasing investments in next-generation detector materials aimed at improving sensitivity, count-rate performance, and manufacturing efficiency are expected to create new opportunities for innovation within the market.

Based on application, the global photon-counting CT market is segmented into oncology, cardiology, neurology, orthopedics, pulmonology, and other applications. The oncology segment accounted for the dominant market share of 29% in 2025, driven by the increasing use of photon-counting CT for early cancer detection, tumor characterization, treatment planning, and therapy monitoring. The segment is projected to reach USD 976.7 million by 2035, growing at a CAGR of 26.6% during the forecast period.

  • Photon-counting CT provides quantitative imaging and material decomposition capabilities, allowing clinicians to differentiate tissues more accurately while reducing radiation exposure. These advantages have increased its adoption in cancer diagnosis, staging, treatment planning, and post-treatment monitoring across major oncology centers worldwide.
  • Furthermore, the growing global burden of cancer, coupled with increasing demand for precision oncology and personalized treatment planning, continues to accelerate the adoption of photon-counting CT in oncology. Ongoing research, expanding clinical validation, and integration with AI-assisted image analysis are further enhancing diagnostic confidence and supporting wider clinical implementation, reinforcing the segment's leadership in the global photon-counting CT market.
  • The cardiology segment is projected to expand at a CAGR of 22% to reach USD 543.5 million by 2035. Photon-counting CT enables superior coronary artery visualization, improved plaque characterization, and enhanced assessment of cardiovascular diseases with lower radiation doses and reduced contrast media requirements. These capabilities support more accurate diagnosis of coronary artery disease and structural heart conditions, driving increasing adoption in cardiovascular imaging.
  • The neurology segment is projected to expand at a CAGR of 24% to reach USD 412.5 million by 2035. The technology provides high-resolution imaging of the brain, enabling improved detection of ischemic stroke, intracranial hemorrhage, neurodegenerative disorders, and cerebral vascular abnormalities. Enhanced tissue differentiation and spectral imaging capabilities are expected to drive growing utilization in neurological diagnostics.
  • The orthopedics segment is projected to expand at a CAGR of 27.3% to reach USD 393 million by 2035. Photon-counting CT offers detailed visualization of bone microarchitecture, fractures, joint disorders, and orthopedic implants with reduced metal artifacts. These advantages improve diagnostic accuracy and surgical planning, supporting increased adoption in orthopedic imaging.

Photon-Counting CT Market, By End Use (2025)

Learn more about the key segments shaping this market

Based on end use, the photon-counting CT market is segmented into hospitals, diagnostic imaging centers, research institutes, and other end users. The hospitals segment accounted for the dominant market share of 63.8% in 2025, driven by the increasing installation of advanced imaging systems in tertiary care hospitals, growing patient volumes, and rising demand for high-precision diagnostic imaging. The segment is projected to reach USD 1.8 billion by 2035, growing at a CAGR of 24.3% during the forecast period.

  • Hospitals are the primary adopters of photon-counting CT systems due to the need for superior image quality, reduced radiation exposure, and enhanced diagnostic accuracy across complex clinical applications, including oncology, cardiology, neurology, and emergency medicine. The growing number of advanced imaging procedures performed in hospitals continues to reinforce the segment's market leadership.
  • Increasing investments in hospital infrastructure, expansion of tertiary healthcare facilities, and growing integration of AI-enabled imaging workflows are accelerating the deployment of photon-counting CT systems. Government funding, favorable reimbursement policies in developed markets, and rising demand for precision diagnostics are further supporting the adoption of these advanced imaging platforms, strengthening the dominance of hospitals in the photon-counting CT market.
  • The diagnostic imaging centers segment is projected to expand at a CAGR of 26.7% to reach USD 665 million by 2035. Diagnostic imaging centers are increasingly investing in advanced CT technologies to improve diagnostic capabilities, enhance patient throughput, and differentiate their service offerings. The growing demand for outpatient imaging services and minimally invasive diagnostic procedures is expected to drive the adoption of photon-counting CT systems in this segment.
  • The research institutes segment is projected to expand at a CAGR of 21.9% to reach USD 259.7 million by 2035. Research institutes play a vital role in the development and clinical validation of photon-counting CT technology. Increasing investments in medical imaging research, detector innovation, and translational studies, along with collaborations between academic institutions and medical device manufacturers, are expected to support the rapid growth of this segment.
  • The other end user segment is projected to expand at a CAGR of 25.8% to reach USD 168.1 million by 2035. This segment includes specialty clinics, ambulatory surgical centers, and other healthcare facilities adopting photon-counting CT systems for selected diagnostic applications. Growing awareness of advanced imaging technologies and the gradual expansion of healthcare infrastructure are expected to contribute to the steady growth of this segment during the forecast period.

U.S. Photon-Counting CT Market, 2022 – 2035 (USD Million)

North America Photon-Counting CT Market

The North America market accounted for the largest global market share of 38% in 2025 and is anticipated to witness substantial growth throughout the forecast period.

  • The U.S. market was valued at USD 56 million and USD 70 million in 2022 and 2023, respectively. The market size reached USD 111.4 million in 2025, growing from USD 88 million in 2024, and is anticipated to grow at a CAGR of 24.2% from 2026 to 2035, reaching USD 956.3 million by 2035.
  • The North America market is significantly driven by the increasing prevalence of chronic diseases, particularly cancer, which is creating strong demand for advanced diagnostic imaging technologies. According to the National Cancer Institute, an estimated 2,041,910 new cancer cases and 618,120 deaths are expected in the U.S. in 2025, highlighting the substantial disease burden in the region. This rising incidence of cancer, along with other chronic conditions such as cardiovascular and neurological disorders, is accelerating the need for highly precise imaging modalities that enable early detection, accurate diagnosis, and effective disease staging. Photon-counting CT systems, with their superior resolution and improved tissue characterization, are increasingly being considered essential tools in addressing these clinical requirements.
  • The growing adoption of advanced CT technologies across healthcare facilities is further supporting market growth in North America. Hospitals and diagnostic centers are actively investing in next-generation imaging solutions to enhance diagnostic accuracy, reduce radiation exposure, and improve workflow efficiency. Photon-counting CT, with its ability to deliver high-resolution imaging and enhanced contrast differentiation, is gaining traction as a premium diagnostic solution in leading healthcare institutions. This shift toward technologically advanced imaging systems, combined with the need to manage increasing patient volumes and complex disease conditions, is driving the expansion of the market across the region.

Europe Photon-Counting CT Market

The Europe market accounted for a significant share of the global market and was valued at USD 84.3 million in 2025.

  • The Europe market is being driven by the substantial burden of chronic diseases, particularly cardiovascular conditions, which require highly precise diagnostic imaging for early detection and management. According to the Organisation for Economic Co-operation and Development (OECD), cardiovascular diseases accounted for one in three deaths (approximately 1.7 million) in 2022 and affected around 62 million people across Europe, highlighting the scale of the clinical challenge. This high disease burden, combined with notable disparities across demographics and regions, is increasing the need for advanced imaging technologies capable of delivering superior image quality and detailed tissue characterization, thereby supporting the adoption of photon-counting CT systems.
  • Europe’s strong emphasis on advanced healthcare delivery and precision diagnostics is accelerating the uptake of next-generation imaging technologies such as photon-counting CT. The technology’s ability to provide higher spatial resolution and improved contrast differentiation is particularly valuable in cardiovascular imaging, where accurate assessment of plaques, vessels, and microstructures is critical. This shift toward precision imaging, combined with the region’s focus on improving clinical outcomes and addressing chronic disease burden, is driving sustained growth in the Europe photon-counting CT industry.

Asia Pacific Photon-Counting CT Market

The Asia Pacific market accounted for a substantial share of the global market and was valued at USD 74.5 million in 2025.

  • The Asia Pacific market is being driven by rapidly expanding healthcare infrastructure, increasing prevalence of chronic diseases, and growing investments in advanced diagnostic imaging technologies across emerging economies. Countries such as China, Japan, South Korea, and India are witnessing rising incidences of cancer, cardiovascular diseases, and neurological disorders, creating strong demand for high-resolution imaging solutions that enable early diagnosis and precision treatment. In addition, governments across the region are increasing healthcare expenditure and promoting the modernization of hospitals with next-generation medical imaging equipment, supporting the adoption of photon-counting CT systems.
  • The presence of rapidly growing medical imaging manufacturers, increasing research and development activities, and expanding access to tertiary healthcare facilities are accelerating market growth across the region. Although high system costs and limited availability remain challenges in several developing countries, ongoing technological advancements, increasing private and public investments in healthcare infrastructure, and rising awareness of precision medicine are expected to position Asia Pacific as the fastest-growing regional market for photon-counting CT during the forecast period.

Latin America Photon-Counting CT Market

The Latin America market is anticipated to exhibit remarkable growth during the forecast period.

  • The growing prevalence of cancer, cardiovascular diseases, and neurological disorders has increased the need for accurate and early disease diagnosis, encouraging healthcare providers to invest in next-generation CT technologies. Countries such as Brazil, Mexico, and Argentina are expanding access to advanced medical imaging through modernization of hospitals and increasing public and private healthcare investments, supporting the adoption of photon-counting CT systems.
  • The market is benefiting from the gradual expansion of diagnostic imaging services, growing government initiatives to strengthen healthcare infrastructure, and increasing collaborations between global medical imaging manufacturers and regional healthcare providers. The adoption of photon-counting CT is further supported by the need for improved image quality, lower radiation exposure, and enhanced diagnostic confidence in complex clinical applications. Although high equipment costs and limited availability of advanced CT systems remain challenges in certain parts of the region, continued healthcare investments, improving access to specialized imaging centers, and increasing awareness of precision diagnostics are expected to drive steady market growth throughout the forecast period.

Middle East and Africa Photon-Counting CT Market

The Middle East and Africa market is expected to experience substantial growth over the forecast period.

  • The Middle East and Africa (MEA) market is being driven by the increasing burden of chronic diseases, growing investments in healthcare infrastructure, and rising demand for advanced diagnostic imaging technologies across the region. Countries such as Saudi Arabia, the UAE, and South Africa are investing significantly in modernizing healthcare facilities and expanding access to high-end diagnostic equipment as part of broader healthcare transformation initiatives. The increasing prevalence of cancer, cardiovascular diseases, and neurological disorders is further driving the need for high-resolution, low-dose imaging solutions, supporting the adoption of photon-counting CT systems.
  • The growing emphasis on early diagnosis and improved clinical efficiency is driving interest in next-generation CT technologies across the region. Although adoption is currently concentrated in advanced healthcare markets, the gradual improvement in healthcare access and increasing investment in premium imaging technologies are expected to support the steady expansion of the market across the MEA region.

Photon-Counting CT Market Share

  • The photon-counting CT industry is highly consolidated, with key players such as Siemens Healthineers, GE HealthCare, Philips, Canon Medical Systems, and United Imaging Healthcare collectively accounting for approximately 90% of the global market.
  • Their dominance is attributed to strong expertise in CT imaging, substantial investments in research and development, extensive global distribution networks, and established relationships with hospitals and diagnostic imaging centers. Siemens Healthineers currently holds the leading position due to being the first company to commercially launch a photon-counting CT system (NAEOTOM Alpha), providing a significant first-mover advantage.
  • Leading companies are actively expanding their technological capabilities and global presence through product innovation, clinical collaborations, regulatory approvals, and strategic investments in advanced imaging technologies. Siemens Healthineers continues to expand its photon-counting CT portfolio with new system variants, while GE HealthCare, Philips, Canon Medical Systems, and United Imaging Healthcare are accelerating the development and commercialization of next-generation photon-counting CT platforms.
  • For instance, Siemens Healthineers has strengthened its leadership through the commercialization of the NAEOTOM Alpha platform and expansion of its product portfolio with NAEOTOM Alpha.Pro and Alpha.Prime, supported by collaborations with leading academic hospitals for clinical validation.
  • GE HealthCare has accelerated development of its Photonova Spectra platform while enhancing its enterprise imaging ecosystem through strategic investments. Philips continues to leverage its expertise in spectral CT imaging and AI-powered workflow solutions, whereas Canon Medical Systems is focusing on detector innovation and ultra-low-dose imaging technologies. United Imaging Healthcare is rapidly expanding its global footprint through cost-competitive advanced CT systems and increasing investments in photon-counting technology. Meanwhile, companies such as Neusoft Medical Systems, Samsung, and Kromek are strengthening the ecosystem through regional expansion, detector innovation, and semiconductor technology development, contributing to future market growth.
  • Collectively, these strategic initiatives are shaping the competitive landscape of the photon-counting CT industry. These efforts are accelerating the replacement of conventional CT systems with next-generation photon-counting platforms and supporting the long-term growth of the global market.

 Photon-Counting CT Market Companies

A few of the prominent players operating in the global photon-counting CT industry include:

  • Canon
  • GE HealthCare
  • Kromek
  • Neusoft Medical Systems
  • PHILIPS
  • Samsung
  • Siemens Healthineers
  • United Imaging Healthcare
  • Philips

Leadership in spectral CT and integrated imaging informatics, supported by AI-enabled workflow solutions and strong hospital partnerships, provides a foundation for transitioning to photon-counting CT technology.

  • Canon

Expertise in detector technology and ultra-low-dose imaging, along with high-quality image reconstruction and precision engineering, strengthens its position in next-generation CT development.

  • United Imaging Healthcare

Cost-competitive innovation, rapid product development, and strong expansion across Asia-Pacific and emerging markets enable it to challenge established global players while investing aggressively in advanced CT technologies.                      

Photon-Counting CT Market Report Attributes
Key TakeawayDetails
Market Size & Growth
Base Year2025
Market Size in 2025USD 322.7 Million
Market Size in 2026USD 395.1 Million
Forecast Period 2026-2035 CAGR 24.7%
Market Size in 2035USD 2.9 Billion
Key Market Trends
DriversImpact
Growing demand for high-resolution diagnostic imagingPhoton-counting CT provides superior spatial resolution, improved tissue characterization, and reduced image noise compared with conventional CT systems. As healthcare providers seek more accurate imaging for early disease detection, demand for PCCT systems is expected to increase significantly.
Increasing prevalence of chronic diseases and cancerThe rising burden of cardiovascular diseases, cancer, neurological disorders, and musculoskeletal conditions increases the need for advanced diagnostic imaging. Photon-counting CT enables earlier diagnosis, better lesion detection, and more accurate disease staging, driving market adoption.
Rising adoption of advanced CT technologies in healthcare facilitiesHospitals and diagnostic centers are increasingly replacing older CT scanners with next-generation imaging technologies. Photon-counting CT is gaining preference due to its enhanced diagnostic performance, spectral imaging capability, and lower radiation dose, supporting market growth.
Technological advancements in detector materials and system designContinuous improvements in semiconductor detector materials (such as cadmium telluride and cadmium zinc telluride), AI-powered image reconstruction, and faster data processing enhance image quality and system efficiency while reducing costs over time. These innovations accelerate commercialization and market expansion.
Pitfalls & ChallengesImpact
High installation and equipment costsPhoton-counting CT systems require sophisticated detector technology and advanced hardware, making them significantly more expensive than conventional CT scanners. High capital investment limits adoption, particularly among small hospitals and healthcare facilities in developing regions.
Shortage of trained professionals for operation and interpretationPhoton-counting CT introduces new imaging capabilities and spectral data that require specialized training for radiologists and technicians. The shortage of experienced professionals can delay implementation and reduce the clinical utilization of these systems.
Limited availability of photon-counting CT systemsThe market currently has a limited number of commercially available systems due to technological complexity and a relatively small number of manufacturers. Limited product availability slows widespread adoption and market penetration.
Opportunities:Impact
Expansion in emerging healthcare marketsRapid healthcare infrastructure development, increasing healthcare expenditure, and government investments in countries across Asia-Pacific, Latin America, and the Middle East create significant opportunities for manufacturers to expand their customer base and increase system installations.
Increasing research and development investmentsRising investments by medical imaging companies, research institutions, and governments support innovations in detector technology, image reconstruction algorithms, and clinical applications. These developments improve system performance, reduce manufacturing costs, and broaden the clinical adoption of photon-counting CT.
Growing adoption in precision medicine and personalized healthcarePrecision medicine relies on accurate disease characterization and individualized treatment planning. Photon-counting CT offers improved tissue differentiation, quantitative imaging, and spectral analysis, making it well suited for personalized diagnostics and therapy monitoring, thereby expanding market demand.
Market Leaders (2025)
Market Leader
  • Siemens Healthineers

    • Market share ~57%
Top Players
  • Siemens Healthineers
  • GE HealthCare
  • PHILIPS
  • Canon
  • United Imaging Healthcare

    • Collective market share ~90%
Competitive Edge
  • Siemens Healthineers- First-mover advantage with the world's first commercially available photon-counting CT scanner NAEOTOM Alpha, extensive clinical validation, strong patent portfolio, and a large global installed base, making it the current technology leader.
  • GE HealthCare- Strong global CT market presence and extensive R&D capabilities, combined with AI-powered imaging solutions and a large customer base that positions the company well for future photon-counting CT commercialization.
Regional Insights
Largest MarketNorth America
Fastest growing MarketAsia Pacific
Emerging countriesIndia, China, Brazil, Mexico, etc.
Future outlook
  • The Photon-Counting CT market is expected to expand significantly, driven by the increasing demand for high-resolution diagnostic imaging, rising prevalence of chronic diseases, and growing adoption of advanced CT technologies across healthcare facilities.
  • Ongoing advancements in photon-counting detector technology, AI-powered image reconstruction, and spectral imaging capabilities, along with increasing investments in precision medicine and healthcare infrastructure, are expected to improve clinical outcomes and support sustained market growth
What are the growth opportunities in this market?

Photon-Counting CT Industry News

  • In March 2026, GE HealthCare announced that it received FDA clearance for its first photon-counting CT (PCCT) scanner, Photonova Spectra, marking its official entry into the commercial PCCT market. This development represented a significant milestone for the company and positioned it as a direct competitor to Siemens Healthineers, which was a pioneer in this technology segment. The launch intensified competition in the high-end CT imaging market and supported the adoption of photon-counting technology across healthcare systems.
  • In December 2024, Siemens Healthineers expanded its photon-counting CT portfolio by introducing the NAEOTOM Alpha.Pro and NAEOTOM Alpha.Prime systems. These models helped broaden access to PCCT technology to more hospitals, including general hospitals and emergency departments. The expansion strengthened Siemens’ position in the photon-counting CT market and supported wider adoption of this technology.

The global photon-counting CT market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • Standalone photon-counting CT systems  
  • Retrofit photon-counting CT solutions

Market, By Detector Type

  • Silicon detectors
  • Cadmium telluride detectors
  • Cadmium zinc telluride (CZT) detectors
  • Others detector types        

Market, By Application

  • Oncology
  • Cardiology
  • Neurology
  • Orthopedics
  • Pulmonology
  • Other application     

Market, By End User

  • Hospital
  • Diagnostic Imaging Centers
  • Research Institutes
  • Other end users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
Authors:  Monali Tayade , Shishanka Wangnoo

Table of Contents

Chapter 1   Research Methodology

Chapter 2   Executive Summary

Chapter 3   Industry Insights

Chapter 4   Competitive Landscape, 2025

Chapter 5   Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

Chapter 6   Market Estimates and Forecast, By Detector Type, 2022 - 2035 ($ Mn)

Chapter 7   Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 ($ Mn)

Chapter 9   Market Estimates and Forecast, By End User, 2022 - 2035 ($ Mn)

Chapter 10   Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

Chapter 11   Company Profiles

Frequently Asked Question(FAQ) :
How big is the photon-counting CT market?
The photon-counting CT market size was estimated at USD 322.7 million in 2025 and is expected to reach USD 395.1 million in 2026.
What is the 2035 forecast for the photon-counting CT market?
The market is projected to reach USD 2.9 billion by 2035, growing at a CAGR of 24.7% from 2026 to 2035.
Which region dominates the photon-counting CT market?
North America currently holds the largest share of the photon-counting CT market in 2025.
Which region is expected to grow the fastest in the photon-counting CT market?
Asia Pacific is projected to be the fastest-growing region during the forecast period.
Who are the major players in photon-counting CT market?
Some of the major players in photon-counting CT market include Siemens Healthineers, GE HealthCare, PHILIPS, Canon, United Imaging Healthcare, which collectively held 90% market share in 2025.
What was the market share of cadmium telluride (CdTe) detectors in 2025?
Cadmium telluride (CdTe) detectors accounted for 85.1% of the market in 2025, driven by their superior photon detection efficiency, enhanced spatial resolution, and widespread integration into commercial photon-counting CT systems.
What is the growth outlook for retrofit photon-counting CT solutions from 2026 to 2035?
Retrofit photon-counting CT solutions are projected to grow at a 32.7% CAGR through 2035, driven by increasing demand for cost-effective upgrades that enable healthcare providers to modernize existing CT systems without complete replacement.

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

  • Macroeconomic factors
  • Microeconomic factors
  • Technology & innovation
  • Regulatory & political environment
  • Demographics
  • Value chain analysis
  • Market dynamics
  • Porter's five forces
  • PESTLE analysis
  • Competitive benchmarking
  • Supply-demand gap analysis
  • Pricing trends
  • SWOT Analysis
  • Mergers & Acquisitions Activity
  • Investment & Funding Landscape
  • Company Profiles

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Related Reports
Authors:  Monali Tayade, Shishanka Wangnoo
img
Get a free sample of this report Photon-Counting CT Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential.
We use cookies to enhance user experience. (Privacy Policy)